slide 1

Back to the List of the Granted Patents                                                Click here to download AP2713 PDF

(11)    Patent No :    AP 2713   
(21)    Application No :    AP/P/2010/005160   
(22)    Filing Date :    13.08.2008   
(24)    Date of Grant &    30.07.2013   
(45)    Publication :

(30)  Priority Data       
(33) Country    (31) Number    (32) Date
GB    0716592.1    24.08.2007
(84)    Designated State

BW    GM    GH    KE    LS    MW  MZ   NA   SL
SD    SZ    T Z    UG    ZM    ZW
(73) Applicant(s)

SYNGENTA LIMITED, European Regional Centre, Priestley Road, Surrey Research Park, Guildford, Surrey GU2 7YH, United Kingdom
(72) Inventors

BELL Gordon Alastair, United Kingdom

HARRIS Clair Louise, United Kingdom

TOVEY Ian David, United Kingdom
et al
(74) Representative
(51)    International  Classification   A01N 25/02 (2006.01)
(54)    Title

Improvements in or relating to organic compounds

(57)    Abstract

A composition comprising a compound of formula (I) CH3CH(OH)C(=0)NR1R2 where R1 and R2 are each independently hydrogen; or C1-6 alkyl, C2-6 alkenyl or C3-6 cycloalkyl, each of which is optionally substituted by up to three substituents independently selected from phenyl, hydroxy, C1-5 alkoxy, morpholinyl and NR3R4 where R3 and R4 are each independently C1-3 alkyl; or phenyl optionally substituted by up to three

substituents independently selected from C1-3 alkyl; or R1 and R2 together with the nitrogen atom to which they are attached form a morpholinyl,

pyrrolidinyl, piperidinyl or azepanyl ring, each of which is opt ionally substituted by up to three substituents independently selected from C1-3

alkyl; and at least one biologically active compound, which comprises at least one aromatic five and/or six membered ring wherein the ring contains at least

one nitrogen as a ring member, with the provisos (i) that the composition does not contain cyproconazole when the compound of formula (1) is

selected from the group consisting of N-butoxypropyl lactamide; l-(hydroxyethyl) piperidinyl lactamide; N-methyl-N-propyl lactamide; N-(l-ethylpropyl) lactamide; N,N-dimethyl lactamide; N-1,4-dimethylpentyl lactamide; N-(2-hydroxyethyl)-N-benzyl lactamide; N-Morpholinyl lactamide; N-methyl-N-butyl lactamide; N-Isobutyl lactamide; N-Allyl lactamide; N-Ethyl lactamide; N-Ethyl-N-(2-hydroxyethyl) lactamide; and N-isopropyl lactamide; and (ii) that the biologically active compound is not nicotinic acid when the compound of formula (1) is diethyl-lactamide. Such compositions may be, or may be comprised by, emulsion concentrates, particularly so in the case that the compound of formula (I) is dimethyl lactamide and the biologically active compound is the fungicide 3-difluoromethyl-1

-methyl-lH -pyrazole -4-carboxylic acid(9-isopropyl-l,2,3,4-tetrahydro -l,4-methano-naphthalen-5-yl)-amide shown in Figure 2.
(56)    Documents Cited :    DE 4130189 A1    WO 2007/107745 A    DE 4112 873 A1


Join our newsletter for CIPIT news through subscriptions!


Social Media


Contact Us

TEL : (254) 703 034 612